PharmTech Europe News

Jan 18, 2018
By Pharmaceutical Technology Editors
The company is developing a pipeline of combination therapies using its patented polymer-based matrix delivery system, known as TAOS (targeted orchestrated signalling matrix).
Jan 02, 2018
Pharmaceutical Technology
Brexit-related challenges cast shadows on prospects for the European bio/pharma market in 2018, but optimism may let some sun shine through.
Dec 19, 2017
By Pharmaceutical Technology Editors
The European Commission has closed its infringement procedure against Roche after the company completed remedial actions.
Dec 19, 2017
By Pharmaceutical Technology Editors
EMA recommends suspending the marketing of modified- or prolonged-released products containing paracetamol due to a difficulty in managing overdose.
Dec 05, 2017
By Pharmaceutical Technology Editors
During the November meeting of the agency’s Pharmacovigilance Risk Assessment Committee, review of Esmya (ulipristal acetate) was announced as well as warnings about prostate cancer treatments.
Dec 05, 2017
By Pharmaceutical Technology Editors
The agency and the European Commission published updated guidance to answer questions about Brexit.
Dec 02, 2017
Pharmaceutical Technology
Amid business and regulatory uncertainty, bio/pharma experts reveal opinions on salary, recognition, and training.
Nov 27, 2017
By Pharmaceutical Technology Editors
The new guidelines discuss GMPs and patient protection specific to advanced therapy medicinal products.
Nov 20, 2017
By Pharmaceutical Technology Editors
Ontruzant is the first biosimilar of Roche’s Herceptin (trastuzumab) to be approved in Europe.
Nov 10, 2017
By Pharmaceutical Technology Editors
Two of the medicines recommended for approval are orphan drugs.
native1_300x100
lorem ipsum